Molecular Endocrinology, Vol 8, 265-273, Copyright © 1994 by Endocrine Society

ARTICLES

DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor

LP Freedman, V Arce and R Perez Fernandez
Cell Biology & Genetics Program Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

DNA binding site discrimination within a subgroup of nuclear receptors, including the human vitamin D3 receptor (hVDR), appears to be influenced primarily by spacing and orientation differences of response element half-sites, since many receptors recognize and bind to the same hexameric half-site sequence, AGGTCA. Small sequence differences within half-sites, however, may also play an important role in distinguishing between different receptor complexes. Several laboratories have reported that the AGGTCA element in a direct repeat (DR) configuration appears to be a high affinity recognition site for only nuclear receptor-9 retinoid X receptor (RXR) heterodimers. However, we have previously shown that a closely related, but distinct, element (AGTTCA; essentially the mouse osteopontin [Spp-1] vitamin D response element) acts as a high affinity target for purified hVDR in the absence of RXR. This suggests that some half-site sequences could be targets for hVDR alone while others serve as recognition elements for hVDR-RXR complexes. In this report, we test this hypothesis by selecting, using purified hVDR only, for high affinity receptor binding sites in a complex DNA mixture which should by chance contain such sequences. We find that the purified receptor selects a heptameric sequence resembling a half-site of the osteopontin vitamin D response element, consistent with osteopontin-like sequences acting as high affinity targets for hVDR in the absence of RXR. We directly test this by comparing the in vitro DNA binding activity of purified hVDR to DR+3 elements comprised of osteopontin-like AGTTCA or AGGTCA half- sites.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. Seoane and R. Perez-Fernandez The Vitamin D Receptor Represses Transcription of the Pituitary Transcription Factor Pit-1 Gene without Involvement of the Retinoid X Receptor Mol. Endocrinol., April 1, 2006; 20(4): 735 - 748. [Abstract] [Full Text] [PDF]

				K. R McGaffin and S. A Chrysogelos Identification and characterization of a response element in the EGFR promoter that mediates transcriptional repression by 1,25-dihydroxyvitamin D3 in breast cancer cells J. Mol. Endocrinol., August 1, 2005; 35(1): 117 - 133. [Abstract] [Full Text] [PDF]

				Y. Shostak, M. R. Van Gilst, A. Antebi, and K. R. Yamamoto Identification of C. elegans DAF-12-binding sites, response elements, and target genes Genes & Dev., October 15, 2004; 18(20): 2529 - 2544. [Abstract] [Full Text] [PDF]

				N. Ikeda, H. Uemura, H. Ishiguro, M. Hori, M. Hosaka, S. Kyo, K.-i. Miyamoto, E. Takeda, and Y. Kubota Combination Treatment with 1{alpha},25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Directly Inhibits Human Telomerase Reverse Transcriptase Transcription in Prostate Cancer Cells Mol. Cancer Ther., August 1, 2003; 2(8): 739 - 746. [Abstract] [Full Text] [PDF]

				P. M. Yen Physiological and Molecular Basis of Thyroid Hormone Action Physiol Rev, July 1, 2001; 81(3): 1097 - 1142. [Abstract] [Full Text] [PDF]

				L. L. Issa, G. M. Leong, J. B. Barry, R. L. Sutherland, and J. A. Eisman Glucocorticoid Receptor-Interacting Protein-1 and Receptor-Associated Coactivator-3 Differentially Interact with the Vitamin D Receptor (VDR) and Regulate VDR-Retinoid X Receptor Transcriptional Cross-Talk Endocrinology, April 1, 2001; 142(4): 1606 - 1615. [Abstract] [Full Text]

				Y.-Y. Liu, C. Nguyen, and S. Peleg Regulation of Ligand-Induced Heterodimerization and Coactivator Interaction by the Activation Function-2 Domain of the Vitamin D Receptor Mol. Endocrinol., November 1, 2000; 14(11): 1776 - 1787. [Abstract] [Full Text]

				C. Rachez, M. Gamble, C.-P. B. Chang, G. B. Atkins, M. A. Lazar, and L. P. Freedman The DRIP Complex and SRC-1/p160 Coactivators Share Similar Nuclear Receptor Binding Determinants but Constitute Functionally Distinct Complexes Mol. Cell. Biol., April 15, 2000; 20(8): 2718 - 2726. [Abstract] [Full Text]

				C. C. Nelson, S. C. Hendy, R. J. Shukin, H. Cheng, N. Bruchovsky, B. F. Koop, and P. S. Rennie Determinants of DNA Sequence Specificity of the Androgen, Progesterone, and Glucocorticoid Receptors: Evidence for Differential Steroid Receptor Response Elements Mol. Endocrinol., December 1, 1999; 13(12): 2090 - 2107. [Abstract] [Full Text]

				S. H. Wang, R. J. Koenig, T. J. Giordano, A. Myc, N. W. Thompson, and J. R. Baker Jr. 1{alpha},25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell Death Endocrinology, April 1, 1999; 140(4): 1649 - 1656. [Abstract] [Full Text]

				N. J. Koszewski, S. Ashok, and J. Russell Turning a Negative into a Positive: Vitamin D Receptor Interactions with the Avian Parathyroid Hormone Response Element Mol. Endocrinol., March 1, 1999; 13(3): 455 - 465. [Abstract] [Full Text]

				L. P. Freedman Transcriptional Targets of the Vitamin D3 Receptor–Mediating Cell Cycle Arrest and Differentiation J. Nutr., February 1, 1999; 129(2): 581 - 581. [Abstract] [Full Text] [PDF]

				M. Raval-Pandya, L. P. Freedman, H. Li, and S. Christakos Thyroid Hormone Receptor Does Not Heterodimerize with the Vitamin D Receptor but Represses Vitamin D Receptor-Mediated Transactivation Mol. Endocrinol., September 1, 1998; 12(9): 1367 - 1379. [Abstract] [Full Text]

				C. Solomon, M. Sebag, J. H. White, J. Rhim, and R. Kremer Disruption of Vitamin D Receptor-Retinoid X Receptor Heterodimer Formation following ras Transformation of Human Keratinocytes J. Biol. Chem., July 10, 1998; 273(28): 17573 - 17578. [Abstract] [Full Text] [PDF]

				C. Rachez, Z. Suldan, J. Ward, C.-P. B. Chang, D. Burakov, H. Erdjument-Bromage, P. Tempst, and L. P. Freedman A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system Genes & Dev., June 15, 1998; 12(12): 1787 - 1800. [Abstract] [Full Text]

				I. Quelo, I. Machuca, and P. Jurdic Identification of a Vitamin D Response Element in the Proximal Promoter of the Chicken Carbonic Anhydrase II Gene J. Biol. Chem., April 24, 1998; 273(17): 10638 - 10646. [Abstract] [Full Text] [PDF]

				P. D. Thompson, P. W. Jurutka, C. A. Haussler, G. K. Whitfield, and M. R. Haussler Heterodimeric DNA Binding by the Vitamin D Receptor and Retinoid X Receptors Is Enhanced by 1,25-Dihydroxyvitamin D3 and Inhibited by 9-cis-Retinoic Acid. EVIDENCE FOR ALLOSTERIC RECEPTOR INTERACTIONS J. Biol. Chem., April 3, 1998; 273(14): 8483 - 8491. [Abstract] [Full Text] [PDF]

				P. M. Yen, Y. Liu, A. Sugawara, and W. W. Chin Vitamin D Receptors Repress Basal Transcription and Exert Dominant Negative Activity on Triiodothyronine-mediated Transcriptional Activity J. Biol. Chem., May 3, 1996; 271(18): 10910 - 10916. [Abstract] [Full Text] [PDF]

				R. W. Katz, J. S. Subauste, and R. J. Koenig The Interplay of Half-site Sequence and Spacing on the Activity of Direct Repeat Thyroid Hormone Response Elements J. Biol. Chem., March 10, 1995; 270(10): 5238 - 5242. [Abstract] [Full Text] [PDF]